Sherry Aulin insider trades
Open-market stock purchases and sales by Sherry Aulin, Chief Financial Officer at Xenon Pharmaceuticals Inc, from SEC Form 4 filings since Jun 3, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- XENE Xenon Pharmaceuticals Inc: 3 sales, last Dec 18, 2024